Search

Search Constraints

You searched for: Author/Creator Galetta, Domenico

Search Results

1. A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy. (October 2016)

2. A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy. (October 2016)

3. A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives. (December 2018)

4. BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. (May 2016)

5. Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients. (February 2020)

7. Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer. Issue 1 (21st November 2019)

8. Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. (February 2018)

9. Chest wall resection and reconstruction for locally recurrent breast cancer: From technical aspects to biological assessment. Issue 1 (February 2016)